Tumor infiltrating lymphocytes (TILs) are a prognosis biomarker in Colombian patients with triple negative breast cancer

por Huertas-Caro, Carlos A., Ramírez, Mayra A., Rey-Vargas, Laura, Bejarano-Rivera, Lina María, Ballen, Diego Felipe, Nuñez, Marcela, Mejía, Juan Carlos, Sua-Villegas, Luz Fernanda, Cock-Rada, Alicia, Zabaleta, Jovanny, Fejerman, Laura, Sanabria-Salas, María Carolina, Serrano-Gomez, Silvia J.
Publicado 2023